Immunoblastic Lymphoma in Persons with AIDS-Associated Kaposi’s Sarcoma: a Role for Kaposi’s Sarcoma–Associated Herpesvirus

Nador, 1996, Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus, Blood, 88, 645, 10.1182/blood.V88.2.645.bloodjournal882645 Cesarman, 1995, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas, N Engl J Med, 332, 1186, 10.1056/NEJM199505043321802 Dupin, 2000, HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma, Blood, 95, 1406, 10.1182/blood.V95.4.1406.004k26_1406_1412 Oksenhendler, 2002, High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease, Blood, 99, 2331, 10.1182/blood.V99.7.2331 Mbulaiteye, 2002, Pleural and peritoneal lymphoma among people with AIDS in the United States, J Acquir Immune Defic Syndr, 29, 418, 10.1097/00126334-200204010-00014 Oksenhendler, 1996, Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients, AIDS, 10, 61, 10.1097/00002030-199601000-00009 Gessain, 1997, Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas, Leukemia, 11, 266, 10.1038/sj.leu.2400549 Otsuki, 1996, Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies, Leukemia, 10, 1358 Boye Hansen, 2000, Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990 to 1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8, Eur J Haematol, 64, 368, 10.1034/j.1600-0609.2000.90126.x Chadburn, 2002, KSHV-positive extra-cavitary lymphomas (EC-PELs) are part of the spectrum of primary effusion lymphomas (PEL) [abstract], Sixth International Conference on Malignancies in AIDS and Other Immunodeficiencies Engels, 2001, Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma, Br J Cancer, 85, 1298, 10.1054/bjoc.2001.2052 Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. Aoki, 2000, Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions, Blood, 96, 1599, 10.1182/blood.V96.4.1599.h8001599_1599_1601 Jaffe, 1996, Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity, Am J Clin Pathol, 105, 141, 10.1093/ajcp/105.2.141 Katano, 2000, Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease, Virology, 269, 335, 10.1006/viro.2000.0196 Parravicini, 2000, Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease, Am J Pathol, 156, 743, 10.1016/S0002-9440(10)64940-1 Jones, 1999, Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells, Blood, 94, 2871, 10.1182/blood.V94.8.2871.420k25_2871_2879 Friborg, 1999, p53 inhibition by the LANA protein of KSHV protects against cell death, Nature, 402, 889, 10.1038/47266 Rivas, 2001, Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53, J Virol, 75, 429, 10.1128/JVI.75.1.429-438.2001